期刊文献+

大黄不同粒径粉体在家兔体内药代动力学的比较研究 被引量:12

Comparison of pharmacokinetics in different particle diameters of Rhubarb powder in rabbits
下载PDF
导出
摘要 目的对大黄细粉与超微粉体在兔体内的药代动力学进行对比研究。方法采用反相高效液相色谱法测定血浆样品中大黄素、大黄酚和大黄酸的含量,用DAS 2.1.1药代动力学分析软件进行数据统计分析。结果大黄素、大黄酚和大黄酸在兔体内呈二室模型,相应的t1/2α大黄细粉组分别为:0.481、1.757、1.401,大黄超微粉组分别为4.693、0.175、0.165。以细粉为参比,由AUC计算大黄超微粉的相对生物利用度为大黄素:112.57%;大黄酸113.32%;大黄酚:176.14%。结论超微粉碎技术可促进大黄有效成分的吸收,提高其生物利用度。 Objective To study the comparison of pharmacokinetic characteristics of different particle diameters in Rhubarb powder in rabbits. Methods The concentration of plasma Trioxymethylanthraquinone, chrysophanol and rhein in rabbits were determined with RPHPLC method. The pharmacokinetic parameters were calculated by DAS ver2.1.1 pharmacokinetic analysis software. Results Trioxymethylanthraquinone, chrysophanol and rhein in rabbits were in two-compartment model, the corresponding t1/2α of Rhubarb powder group were 0.481, 1.757 and 1.401, the rhubarb ultra-fine powder group 4.693, 0.175 and 0.165. In reference of Rhubarb powder, the relative bioavailability were Trioxymethylanthraquinone 112.57%; Chrysophanol 113.32% and Rhein 176.14%. Conclusion Rhubarb ultra-fine powder can promote the absorption of active ingredients in Rhubarb and increase bioavailability of rhubarb powder.
出处 《湖南中医药大学学报》 CAS 2009年第4期37-40,共4页 Journal of Hunan University of Chinese Medicine
基金 湖南省卫生厅中医药科研基金资助项目(222103)
关键词 大黄 大黄超微粉 大黄细粉 大黄素 大黄酚 大黄酸 家兔 药代动力学 Rhubarb Rhubarb ultra-fine powder, Rhubarb fine powder , trioxymethylan-thraquinone 3-methylchrysazin rheic acid rabbits Phannacokinetics
  • 相关文献

参考文献7

二级参考文献32

  • 1李中原,涂秀华.红花黄色素的药理研究进展[J].中药新药与临床药理,2005,16(2):153-156. 被引量:113
  • 2Chen S J,同济医科大学学报,2000年,20卷,1期,39页
  • 3Guo D L,Acta Pharmacol Sin,1997年,18卷,4期,348页
  • 4Ham YM,Chun KH,Choi JS,Kim DH,Lee SK.SEK1-dependent JNK1 activation prolongs cell survival during G-Rh2-induced apoptosis[J].Biochem Biophys Res Commun,2003;304:358-64
  • 5Tatsuka M,Maeda M,Ota T.Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh2[J].Jap J Cancer Res,2001;92:1184-9
  • 6Fei XF,Wang BX,Tashiro S,Li TJ,Ma JS,Ikejima T.Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells[J].Acta Pharmacol Sin,2002;23:315-22
  • 7Cheng CC,Yang SM,Huang CY,Chen JC,Chang WM,Hsu SL.Molecular mechanisms of ginsenoside Rh2-mediated G(1) growth arrest and apoptosis in human lung adenocarcinoma A549 cells[J].Cancer Chemother Pharmacol,2005;55:531-40
  • 8Park EK,Choo MK,Oh JK,Ryu JH,Kim DH.Ginsenoside Rh2 reduces ischemic brain injury in rats[J].Biol Pharm Bull,2004;27:433-6
  • 9Bae EA,Hyun YJ,Choo MK,Oh JK,Ryu JH,Kim DH.Protective effect of fermented red ginseng on a transient focal ischemic rats[J].Arch Pharm Res,2004;27:1136-40
  • 10Park EK,Choo MK,Kim EJ,Han MJ,Kim DH.Antiallergic activity of ginsenoside Rh2[J].Biol Pharm Bull,2003;26:1581-4

共引文献122

同被引文献148

引证文献12

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部